GAN (GAN) Competitors $1.80 +0.01 (+0.28%) As of 12:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GAN vs. ECX, GRRR, CRNC, RXT, KLTR, DH, GMGI, DOMO, MTLS, and HCATShould you be buying GAN stock or one of its competitors? The main competitors of GAN include ECARX (ECX), Gorilla Technology Group (GRRR), Cerence (CRNC), Rackspace Technology (RXT), Kaltura (KLTR), Definitive Healthcare (DH), Golden Matrix Group (GMGI), Domo (DOMO), Materialise (MTLS), and Health Catalyst (HCAT). These companies are all part of the "computer software" industry. GAN vs. ECARX Gorilla Technology Group Cerence Rackspace Technology Kaltura Definitive Healthcare Golden Matrix Group Domo Materialise Health Catalyst GAN (NASDAQ:GAN) and ECARX (NASDAQ:ECX) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, community ranking, earnings and risk. Does the media prefer GAN or ECX? In the previous week, GAN had 5 more articles in the media than ECARX. MarketBeat recorded 11 mentions for GAN and 6 mentions for ECARX. ECARX's average media sentiment score of 0.51 beat GAN's score of 0.34 indicating that ECARX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GAN 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral ECARX 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer GAN or ECX? GAN received 9 more outperform votes than ECARX when rated by MarketBeat users. However, 100.00% of users gave ECARX an outperform vote while only 33.33% of users gave GAN an outperform vote. CompanyUnderperformOutperformGANOutperform Votes1133.33% Underperform Votes2266.67% ECARXOutperform Votes2100.00% Underperform VotesNo Votes Do analysts rate GAN or ECX? ECARX has a consensus target price of $3.20, suggesting a potential upside of 137.04%. Given ECARX's stronger consensus rating and higher probable upside, analysts clearly believe ECARX is more favorable than GAN.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GAN 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00ECARX 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of GAN or ECX? 16.7% of GAN shares are held by institutional investors. 8.5% of GAN shares are held by insiders. Comparatively, 20.0% of ECARX shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, GAN or ECX? GAN has a beta of 1.88, meaning that its stock price is 88% more volatile than the S&P 500. Comparatively, ECARX has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Is GAN or ECX more profitable? GAN has a net margin of -9.84% compared to ECARX's net margin of -22.01%. Company Net Margins Return on Equity Return on Assets GAN-9.84% N/A -15.85% ECARX -22.01%N/A -30.30% Which has higher valuation and earnings, GAN or ECX? GAN has higher earnings, but lower revenue than ECARX. GAN is trading at a lower price-to-earnings ratio than ECARX, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGAN$135.00M0.61-$34.44M-$0.18-9.99ECARX$5.56B0.09-$132.42M-$0.39-3.46 SummaryGAN beats ECARX on 9 of the 17 factors compared between the two stocks. Get GAN News Delivered to You Automatically Sign up to receive the latest news and ratings for GAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GAN vs. The Competition Export to ExcelMetricGANComputer & Data IndustryComputer SectorNASDAQ ExchangeMarket Cap$82.20M$72.82B$23.52B$7.93BDividend YieldN/A2.02%2.97%4.22%P/E Ratio-5.9876.9942.4918.49Price / Sales0.61184.722,087.22102.66Price / CashN/A30.1934.7234.62Price / Book-17.994.486.194.25Net Income-$34.44M$3.40B$739.49M$248.31M7 Day Performance3.39%2.40%1.80%1.12%1 Month Performance2.22%-1.29%2.10%3.68%1 Year Performance51.18%39.84%52,785.36%5.19% GAN Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GANGAN0.3047 of 5 stars$1.80+0.3%N/A+51.7%$82.20M$135.00M-5.98680Upcoming EarningsECXECARX2.1854 of 5 stars$0.84-6.6%$3.20+278.9%-20.7%$313.08M$5.56B-1.692,000Earnings ReportNews CoverageGap DownGRRRGorilla Technology Group0.9252 of 5 stars$16.94-12.2%$18.00+6.3%+236.7%$312.80M$78.94M0.00244Short Interest ↓Gap DownCRNCCerence2.152 of 5 stars$7.10-6.5%$8.60+21.1%-0.5%$306.71M$244.07M-0.471,700Upcoming EarningsPositive NewsGap UpRXTRackspace Technology0.6776 of 5 stars$1.27-3.8%$2.15+69.3%-20.9%$301.38M$2.74B-0.336,600Upcoming EarningsShort Interest ↑News CoverageKLTRKaltura1.0013 of 5 stars$1.93-2.0%$2.25+16.6%+74.8%$297.49M$178.72M-9.19680Upcoming EarningsShort Interest ↓News CoveragePositive NewsDHDefinitive Healthcare2.9178 of 5 stars$2.51-0.8%$5.35+113.1%-60.8%$283.41M$252.20M-0.81970Upcoming EarningsNews CoveragePositive NewsGMGIGolden Matrix Group2.7771 of 5 stars$2.09+1.5%$4.00+91.4%-47.6%$276.06M$151.12M0.0030DOMODomo4.3366 of 5 stars$6.82-1.6%$10.25+50.3%-1.3%$272.39M$317.04M-3.11920MTLSMaterialise0.7046 of 5 stars$4.51-4.4%$9.50+110.6%-1.5%$266.41M$266.77M18.042,330Earnings ReportHCATHealth Catalyst4.5024 of 5 stars$3.58-6.8%$8.36+133.6%-36.5%$251.36M$306.58M-2.651,200Upcoming Earnings Related Companies and Tools Related Companies ECX Competitors GRRR Competitors CRNC Competitors RXT Competitors KLTR Competitors DH Competitors GMGI Competitors DOMO Competitors MTLS Competitors HCAT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GAN) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GAN Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share GAN With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.